Read More Healthcare Industry News Sorrento Therapeutics acquires majority stake in Zhengzhou FortuneBio Sorrento Therapeutics has acquired a majority stake in Zhengzhou Fortune Bioscience (Zhengzhou FortuneBio), a Chinese diagnostic manufacturer, for… byPallavi MadhirajuFebruary 20, 2022